nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—Vinca Alkaloids—Vinorelbine—ovarian cancer	0.245	1	CiPCiCtD
Vinblastine—Vinorelbine—ovarian cancer	0.186	1	CrCtD
Vinblastine—NR5A1—ovarian cancer	0.069	0.607	CbGaD
Vinblastine—breast cancer—ovarian cancer	0.0561	0.404	CtDrD
Vinblastine—Vindesine—Vinorelbine—ovarian cancer	0.0438	0.379	CrCrCtD
Vinblastine—Vincristine—Vinorelbine—ovarian cancer	0.0438	0.379	CrCrCtD
Vinblastine—testicular cancer—ovarian cancer	0.0423	0.305	CtDrD
Vinblastine—germ cell cancer—ovarian cancer	0.0405	0.292	CtDrD
Vinblastine—TUBB3—ovarian cancer	0.0396	0.348	CbGaD
Vinblastine—Voacamine—Vinorelbine—ovarian cancer	0.028	0.242	CrCrCtD
Vinblastine—TUBB8—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB2A—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB2B—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB4A—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB3—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB6—Vinorelbine—ovarian cancer	0.00698	0.0478	CbGbCtD
Vinblastine—TUBB4B—Vinorelbine—ovarian cancer	0.00584	0.0399	CbGbCtD
Vinblastine—TUBB—Vinorelbine—ovarian cancer	0.00584	0.0399	CbGbCtD
Vinblastine—TUBB1—Vinorelbine—ovarian cancer	0.00584	0.0399	CbGbCtD
Vinblastine—ABCB1—ovarian cancer	0.00508	0.0447	CbGaD
Vinblastine—TUBB6—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB2A—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB2B—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB4A—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB3—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB8—Paclitaxel—ovarian cancer	0.0049	0.0335	CbGbCtD
Vinblastine—TUBB4B—Paclitaxel—ovarian cancer	0.0041	0.0281	CbGbCtD
Vinblastine—TUBB—Paclitaxel—ovarian cancer	0.0041	0.0281	CbGbCtD
Vinblastine—TUBB1—Paclitaxel—ovarian cancer	0.0041	0.0281	CbGbCtD
Vinblastine—TUBB2A—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB3—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB4A—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB2B—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB6—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB8—Docetaxel—ovarian cancer	0.00354	0.0243	CbGbCtD
Vinblastine—TUBB—Docetaxel—ovarian cancer	0.00297	0.0203	CbGbCtD
Vinblastine—TUBB4B—Docetaxel—ovarian cancer	0.00297	0.0203	CbGbCtD
Vinblastine—TUBB1—Docetaxel—ovarian cancer	0.00297	0.0203	CbGbCtD
Vinblastine—ABCC6—Doxorubicin—ovarian cancer	0.00221	0.0151	CbGbCtD
Vinblastine—NR5A1—corpus luteum—ovarian cancer	0.0019	0.11	CbGeAlD
Vinblastine—ABCB11—Paclitaxel—ovarian cancer	0.0017	0.0117	CbGbCtD
Vinblastine—NR5A1—ovarian follicle—ovarian cancer	0.00149	0.0862	CbGeAlD
Vinblastine—ABCC1—Epirubicin—ovarian cancer	0.00123	0.0084	CbGbCtD
Vinblastine—ABCC1—Paclitaxel—ovarian cancer	0.00121	0.00828	CbGbCtD
Vinblastine—ABCB11—Doxorubicin—ovarian cancer	0.000918	0.00628	CbGbCtD
Vinblastine—ABCC2—Paclitaxel—ovarian cancer	0.000895	0.00613	CbGbCtD
Vinblastine—ABCC1—Docetaxel—ovarian cancer	0.000875	0.00599	CbGbCtD
Vinblastine—ABCC2—Carboplatin—ovarian cancer	0.000843	0.00577	CbGbCtD
Vinblastine—ABCC1—Doxorubicin—ovarian cancer	0.000652	0.00446	CbGbCtD
Vinblastine—ABCC2—Docetaxel—ovarian cancer	0.000647	0.00443	CbGbCtD
Vinblastine—ABCB1—Topotecan—ovarian cancer	0.00059	0.00404	CbGbCtD
Vinblastine—ABCC2—Doxorubicin—ovarian cancer	0.000483	0.0033	CbGbCtD
Vinblastine—ABCB1—Vinorelbine—ovarian cancer	0.000415	0.00284	CbGbCtD
Vinblastine—CYP2D6—Vinorelbine—ovarian cancer	0.000391	0.00268	CbGbCtD
Vinblastine—TUBA1A—oviduct—ovarian cancer	0.000388	0.0225	CbGeAlD
Vinblastine—JUN—oviduct—ovarian cancer	0.000385	0.0223	CbGeAlD
Vinblastine—CYP3A4—Topotecan—ovarian cancer	0.000353	0.00242	CbGbCtD
Vinblastine—Vinorelbine—TUBB3—ovarian cancer	0.000307	0.442	CrCbGaD
Vinblastine—ABCB1—Paclitaxel—ovarian cancer	0.000292	0.002	CbGbCtD
Vinblastine—TUBB4B—oviduct—ovarian cancer	0.000259	0.015	CbGeAlD
Vinblastine—TUBD1—myometrium—ovarian cancer	0.000256	0.0148	CbGeAlD
Vinblastine—CYP3A4—Vinorelbine—ovarian cancer	0.000249	0.0017	CbGbCtD
Vinblastine—TUBD1—embryo—ovarian cancer	0.000246	0.0142	CbGeAlD
Vinblastine—TUBE1—myometrium—ovarian cancer	0.00024	0.0139	CbGeAlD
Vinblastine—Vincristine—TUBB3—ovarian cancer	0.000233	0.335	CrCbGaD
Vinblastine—TUBG1—myometrium—ovarian cancer	0.000215	0.0124	CbGeAlD
Vinblastine—ABCB1—Docetaxel—ovarian cancer	0.000211	0.00144	CbGbCtD
Vinblastine—TUBD1—uterine cervix—ovarian cancer	0.000199	0.0115	CbGeAlD
Vinblastine—TUBE1—uterine cervix—ovarian cancer	0.000187	0.0108	CbGeAlD
Vinblastine—TUBD1—endometrium—ovarian cancer	0.00018	0.0104	CbGeAlD
Vinblastine—TUBE1—decidua—ovarian cancer	0.000178	0.0103	CbGeAlD
Vinblastine—CYP3A4—Paclitaxel—ovarian cancer	0.000175	0.0012	CbGbCtD
Vinblastine—TUBE1—endometrium—ovarian cancer	0.000169	0.00977	CbGeAlD
Vinblastine—TUBG1—uterine cervix—ovarian cancer	0.000167	0.00967	CbGeAlD
Vinblastine—TUBG1—decidua—ovarian cancer	0.000159	0.00922	CbGeAlD
Vinblastine—ABCB1—Doxorubicin—ovarian cancer	0.000157	0.00108	CbGbCtD
Vinblastine—TUBE1—gonad—ovarian cancer	0.000156	0.00907	CbGeAlD
Vinblastine—TUBG1—endometrium—ovarian cancer	0.000151	0.00875	CbGeAlD
Vinblastine—TUBD1—female reproductive system—ovarian cancer	0.000149	0.00864	CbGeAlD
Vinblastine—CYP2D6—Doxorubicin—ovarian cancer	0.000148	0.00101	CbGbCtD
Vinblastine—TUBD1—bone marrow—ovarian cancer	0.000141	0.00815	CbGeAlD
Vinblastine—TUBG1—gonad—ovarian cancer	0.00014	0.00811	CbGeAlD
Vinblastine—TUBE1—female reproductive system—ovarian cancer	0.00014	0.0081	CbGeAlD
Vinblastine—TUBG1—uterus—ovarian cancer	0.000139	0.00806	CbGeAlD
Vinblastine—NR5A1—gonad—ovarian cancer	0.000137	0.00791	CbGeAlD
Vinblastine—TUBD1—female gonad—ovarian cancer	0.000136	0.00786	CbGeAlD
Vinblastine—TUBD1—vagina—ovarian cancer	0.000135	0.00781	CbGeAlD
Vinblastine—TUBE1—bone marrow—ovarian cancer	0.000132	0.00764	CbGeAlD
Vinblastine—TUBE1—female gonad—ovarian cancer	0.000127	0.00737	CbGeAlD
Vinblastine—TUBB1—decidua—ovarian cancer	0.000126	0.00733	CbGeAlD
Vinblastine—CYP3A4—Docetaxel—ovarian cancer	0.000126	0.000865	CbGbCtD
Vinblastine—TUBE1—vagina—ovarian cancer	0.000126	0.00732	CbGeAlD
Vinblastine—TUBG1—female reproductive system—ovarian cancer	0.000125	0.00725	CbGeAlD
Vinblastine—TUBA1A—myometrium—ovarian cancer	0.000124	0.0072	CbGeAlD
Vinblastine—JUN—myometrium—ovarian cancer	0.000123	0.00713	CbGeAlD
Vinblastine—NR5A1—female reproductive system—ovarian cancer	0.000122	0.00707	CbGeAlD
Vinblastine—TUBB8—testis—ovarian cancer	0.00012	0.00697	CbGeAlD
Vinblastine—TUBD1—testis—ovarian cancer	0.00012	0.00697	CbGeAlD
Vinblastine—TUBA1A—embryo—ovarian cancer	0.000119	0.00692	CbGeAlD
Vinblastine—JUN—embryo—ovarian cancer	0.000118	0.00686	CbGeAlD
Vinblastine—TUBG1—bone marrow—ovarian cancer	0.000118	0.00684	CbGeAlD
Vinblastine—TUBG1—female gonad—ovarian cancer	0.000114	0.00659	CbGeAlD
Vinblastine—TUBG1—vagina—ovarian cancer	0.000113	0.00655	CbGeAlD
Vinblastine—TUBE1—testis—ovarian cancer	0.000113	0.00653	CbGeAlD
Vinblastine—NR5A1—female gonad—ovarian cancer	0.000111	0.00643	CbGeAlD
Vinblastine—TUBB2B—myometrium—ovarian cancer	0.000103	0.00594	CbGeAlD
Vinblastine—TUBB4A—embryo—ovarian cancer	0.000102	0.00592	CbGeAlD
Vinblastine—TUBG1—testis—ovarian cancer	0.000101	0.00585	CbGeAlD
Vinblastine—NR5A1—testis—ovarian cancer	9.85e-05	0.0057	CbGeAlD
Vinblastine—TUBA1A—epithelium—ovarian cancer	9.75e-05	0.00565	CbGeAlD
Vinblastine—TUBB—myometrium—ovarian cancer	9.71e-05	0.00563	CbGeAlD
Vinblastine—TUBA1A—uterine cervix—ovarian cancer	9.67e-05	0.0056	CbGeAlD
Vinblastine—TUBB2A—myometrium—ovarian cancer	9.66e-05	0.0056	CbGeAlD
Vinblastine—JUN—epithelium—ovarian cancer	9.66e-05	0.00559	CbGeAlD
Vinblastine—JUN—uterine cervix—ovarian cancer	9.57e-05	0.00555	CbGeAlD
Vinblastine—TUBB6—myometrium—ovarian cancer	9.53e-05	0.00552	CbGeAlD
Vinblastine—CYP3A4—Doxorubicin—ovarian cancer	9.43e-05	0.000645	CbGbCtD
Vinblastine—TUBB1—bone marrow—ovarian cancer	9.39e-05	0.00544	CbGeAlD
Vinblastine—TUBA1A—decidua—ovarian cancer	9.21e-05	0.00534	CbGeAlD
Vinblastine—JUN—decidua—ovarian cancer	9.12e-05	0.00528	CbGeAlD
Vinblastine—TUBA1A—endometrium—ovarian cancer	8.74e-05	0.00507	CbGeAlD
Vinblastine—TUBD1—lymph node—ovarian cancer	8.72e-05	0.00505	CbGeAlD
Vinblastine—JUN—endometrium—ovarian cancer	8.66e-05	0.00502	CbGeAlD
Vinblastine—Voacamine—ABCB1—ovarian cancer	8.51e-05	0.122	CrCbGaD
Vinblastine—TUBB4B—myometrium—ovarian cancer	8.28e-05	0.0048	CbGeAlD
Vinblastine—TUBB4A—uterine cervix—ovarian cancer	8.26e-05	0.00479	CbGeAlD
Vinblastine—TUBB3—testis—ovarian cancer	8.21e-05	0.00476	CbGeAlD
Vinblastine—TUBE1—lymph node—ovarian cancer	8.18e-05	0.00474	CbGeAlD
Vinblastine—TUBA1A—gonad—ovarian cancer	8.11e-05	0.0047	CbGeAlD
Vinblastine—TUBA1A—uterus—ovarian cancer	8.06e-05	0.00467	CbGeAlD
Vinblastine—JUN—gonad—ovarian cancer	8.03e-05	0.00465	CbGeAlD
Vinblastine—TUBB1—testis—ovarian cancer	8.03e-05	0.00465	CbGeAlD
Vinblastine—TUBB2B—uterine cervix—ovarian cancer	7.98e-05	0.00463	CbGeAlD
Vinblastine—JUN—uterus—ovarian cancer	7.98e-05	0.00462	CbGeAlD
Vinblastine—TUBB4B—embryo—ovarian cancer	7.96e-05	0.00461	CbGeAlD
Vinblastine—TUBB—uterine cervix—ovarian cancer	7.56e-05	0.00438	CbGeAlD
Vinblastine—TUBB2A—uterine cervix—ovarian cancer	7.52e-05	0.00435	CbGeAlD
Vinblastine—TUBB6—epithelium—ovarian cancer	7.48e-05	0.00433	CbGeAlD
Vinblastine—TUBB6—uterine cervix—ovarian cancer	7.41e-05	0.00429	CbGeAlD
Vinblastine—TUBG1—lymph node—ovarian cancer	7.32e-05	0.00424	CbGeAlD
Vinblastine—TUBA1A—female reproductive system—ovarian cancer	7.24e-05	0.0042	CbGeAlD
Vinblastine—TUBB2B—endometrium—ovarian cancer	7.22e-05	0.00418	CbGeAlD
Vinblastine—TUBB—decidua—ovarian cancer	7.2e-05	0.00417	CbGeAlD
Vinblastine—JUN—female reproductive system—ovarian cancer	7.17e-05	0.00416	CbGeAlD
Vinblastine—TUBB2A—decidua—ovarian cancer	7.16e-05	0.00415	CbGeAlD
Vinblastine—Neuropathy peripheral—Topotecan—ovarian cancer	7.12e-05	0.0041	CcSEcCtD
Vinblastine—TUBB6—decidua—ovarian cancer	7.06e-05	0.00409	CbGeAlD
Vinblastine—Neuropathy peripheral—Melphalan—ovarian cancer	6.97e-05	0.00402	CcSEcCtD
Vinblastine—TUBB4A—gonad—ovarian cancer	6.93e-05	0.00402	CbGeAlD
Vinblastine—TUBB4A—uterus—ovarian cancer	6.89e-05	0.00399	CbGeAlD
Vinblastine—TUBA1A—bone marrow—ovarian cancer	6.84e-05	0.00396	CbGeAlD
Vinblastine—TUBB—endometrium—ovarian cancer	6.83e-05	0.00396	CbGeAlD
Vinblastine—TUBB2A—endometrium—ovarian cancer	6.8e-05	0.00394	CbGeAlD
Vinblastine—Angina pectoris—Vinorelbine—ovarian cancer	6.79e-05	0.00391	CcSEcCtD
Vinblastine—JUN—bone marrow—ovarian cancer	6.77e-05	0.00392	CbGeAlD
Vinblastine—Neoplasm—Paclitaxel—ovarian cancer	6.76e-05	0.00389	CcSEcCtD
Vinblastine—TUBB6—endometrium—ovarian cancer	6.7e-05	0.00388	CbGeAlD
Vinblastine—TUBB2B—gonad—ovarian cancer	6.7e-05	0.00388	CbGeAlD
Vinblastine—Pancytopenia—Vinorelbine—ovarian cancer	6.62e-05	0.00381	CcSEcCtD
Vinblastine—Bone pain—Docetaxel—ovarian cancer	6.61e-05	0.00381	CcSEcCtD
Vinblastine—TUBA1A—female gonad—ovarian cancer	6.59e-05	0.00382	CbGeAlD
Vinblastine—Haemoglobin—Topotecan—ovarian cancer	6.55e-05	0.00378	CcSEcCtD
Vinblastine—TUBA1A—vagina—ovarian cancer	6.55e-05	0.0038	CbGeAlD
Vinblastine—JUN—female gonad—ovarian cancer	6.53e-05	0.00378	CbGeAlD
Vinblastine—Haemorrhage—Topotecan—ovarian cancer	6.52e-05	0.00376	CcSEcCtD
Vinblastine—Hypoaesthesia—Topotecan—ovarian cancer	6.49e-05	0.00374	CcSEcCtD
Vinblastine—JUN—vagina—ovarian cancer	6.49e-05	0.00376	CbGeAlD
Vinblastine—Alopecia—Chlorambucil—ovarian cancer	6.47e-05	0.00373	CcSEcCtD
Vinblastine—Pharyngitis—Topotecan—ovarian cancer	6.47e-05	0.00373	CcSEcCtD
Vinblastine—TUBB4B—uterine cervix—ovarian cancer	6.44e-05	0.00373	CbGeAlD
Vinblastine—Haemoglobin—Melphalan—ovarian cancer	6.42e-05	0.0037	CcSEcCtD
Vinblastine—Haemorrhage—Melphalan—ovarian cancer	6.39e-05	0.00368	CcSEcCtD
Vinblastine—TUBB—uterus—ovarian cancer	6.3e-05	0.00365	CbGeAlD
Vinblastine—Phlebitis—Paclitaxel—ovarian cancer	6.3e-05	0.00363	CcSEcCtD
Vinblastine—TUBB2A—uterus—ovarian cancer	6.26e-05	0.00363	CbGeAlD
Vinblastine—TUBB6—gonad—ovarian cancer	6.22e-05	0.0036	CbGeAlD
Vinblastine—ABCB11—testis—ovarian cancer	6.2e-05	0.00359	CbGeAlD
Vinblastine—TUBB4A—female reproductive system—ovarian cancer	6.19e-05	0.00359	CbGeAlD
Vinblastine—TUBB6—uterus—ovarian cancer	6.18e-05	0.00358	CbGeAlD
Vinblastine—TUBB4B—decidua—ovarian cancer	6.14e-05	0.00356	CbGeAlD
Vinblastine—Acute coronary syndrome—Vinorelbine—ovarian cancer	6.13e-05	0.00353	CcSEcCtD
Vinblastine—Neuropathy peripheral—Vinorelbine—ovarian cancer	6.09e-05	0.00351	CcSEcCtD
Vinblastine—Myocardial infarction—Vinorelbine—ovarian cancer	6.09e-05	0.00351	CcSEcCtD
Vinblastine—Deafness—Paclitaxel—ovarian cancer	6.06e-05	0.00349	CcSEcCtD
Vinblastine—Ileus—Epirubicin—ovarian cancer	6.04e-05	0.00348	CcSEcCtD
Vinblastine—TUBB2B—female reproductive system—ovarian cancer	5.98e-05	0.00347	CbGeAlD
Vinblastine—Nystagmus—Epirubicin—ovarian cancer	5.98e-05	0.00345	CcSEcCtD
Vinblastine—ABCC1—myometrium—ovarian cancer	5.9e-05	0.00342	CbGeAlD
Vinblastine—Anaemia—Chlorambucil—ovarian cancer	5.89e-05	0.0034	CcSEcCtD
Vinblastine—TUBA1A—testis—ovarian cancer	5.85e-05	0.00339	CbGeAlD
Vinblastine—TUBB4B—endometrium—ovarian cancer	5.83e-05	0.00338	CbGeAlD
Vinblastine—Agranulocytosis—Vinorelbine—ovarian cancer	5.8e-05	0.00334	CcSEcCtD
Vinblastine—JUN—testis—ovarian cancer	5.79e-05	0.00335	CbGeAlD
Vinblastine—Alopecia—Topotecan—ovarian cancer	5.76e-05	0.00332	CcSEcCtD
Vinblastine—Neoplasm—Docetaxel—ovarian cancer	5.73e-05	0.0033	CcSEcCtD
Vinblastine—Neuritis—Epirubicin—ovarian cancer	5.72e-05	0.0033	CcSEcCtD
Vinblastine—Leukopenia—Chlorambucil—ovarian cancer	5.71e-05	0.00329	CcSEcCtD
Vinblastine—Alopecia—Melphalan—ovarian cancer	5.64e-05	0.00325	CcSEcCtD
Vinblastine—TUBB4A—female gonad—ovarian cancer	5.63e-05	0.00326	CbGeAlD
Vinblastine—TUBB2A—female reproductive system—ovarian cancer	5.63e-05	0.00326	CbGeAlD
Vinblastine—Ileus—Doxorubicin—ovarian cancer	5.58e-05	0.00322	CcSEcCtD
Vinblastine—TUBB6—female reproductive system—ovarian cancer	5.55e-05	0.00322	CbGeAlD
Vinblastine—Hypoaesthesia—Vinorelbine—ovarian cancer	5.55e-05	0.0032	CcSEcCtD
Vinblastine—Cerebrovascular accident—Paclitaxel—ovarian cancer	5.53e-05	0.00319	CcSEcCtD
Vinblastine—Nystagmus—Doxorubicin—ovarian cancer	5.53e-05	0.00319	CcSEcCtD
Vinblastine—Convulsion—Chlorambucil—ovarian cancer	5.53e-05	0.00318	CcSEcCtD
Vinblastine—TUBB2B—female gonad—ovarian cancer	5.44e-05	0.00315	CbGeAlD
Vinblastine—TUBB2B—vagina—ovarian cancer	5.41e-05	0.00313	CbGeAlD
Vinblastine—TUBB4B—gonad—ovarian cancer	5.41e-05	0.00313	CbGeAlD
Vinblastine—TUBB4B—uterus—ovarian cancer	5.37e-05	0.00311	CbGeAlD
Vinblastine—TUBB—bone marrow—ovarian cancer	5.34e-05	0.0031	CbGeAlD
Vinblastine—Phlebitis—Docetaxel—ovarian cancer	5.34e-05	0.00307	CcSEcCtD
Vinblastine—TUBB2A—bone marrow—ovarian cancer	5.32e-05	0.00308	CbGeAlD
Vinblastine—Neuritis—Doxorubicin—ovarian cancer	5.29e-05	0.00305	CcSEcCtD
Vinblastine—Ill-defined disorder—Topotecan—ovarian cancer	5.27e-05	0.00303	CcSEcCtD
Vinblastine—Anaemia—Topotecan—ovarian cancer	5.25e-05	0.00302	CcSEcCtD
Vinblastine—TUBB6—bone marrow—ovarian cancer	5.24e-05	0.00304	CbGeAlD
Vinblastine—TUBB—female gonad—ovarian cancer	5.15e-05	0.00298	CbGeAlD
Vinblastine—Deafness—Docetaxel—ovarian cancer	5.14e-05	0.00296	CcSEcCtD
Vinblastine—Anaemia—Melphalan—ovarian cancer	5.14e-05	0.00296	CcSEcCtD
Vinblastine—TUBB2A—female gonad—ovarian cancer	5.12e-05	0.00297	CbGeAlD
Vinblastine—TUBB—vagina—ovarian cancer	5.12e-05	0.00297	CbGeAlD
Vinblastine—Malaise—Topotecan—ovarian cancer	5.12e-05	0.00295	CcSEcCtD
Vinblastine—Thrombocytopenia—Chlorambucil—ovarian cancer	5.1e-05	0.00294	CcSEcCtD
Vinblastine—TUBB2A—vagina—ovarian cancer	5.09e-05	0.00295	CbGeAlD
Vinblastine—Leukopenia—Topotecan—ovarian cancer	5.08e-05	0.00293	CcSEcCtD
Vinblastine—TUBB6—female gonad—ovarian cancer	5.05e-05	0.00293	CbGeAlD
Vinblastine—TUBB6—vagina—ovarian cancer	5.02e-05	0.00291	CbGeAlD
Vinblastine—TUBB4A—testis—ovarian cancer	5e-05	0.00289	CbGeAlD
Vinblastine—Leukopenia—Melphalan—ovarian cancer	4.98e-05	0.00287	CcSEcCtD
Vinblastine—Anorexia—Chlorambucil—ovarian cancer	4.96e-05	0.00286	CcSEcCtD
Vinblastine—Alopecia—Vinorelbine—ovarian cancer	4.93e-05	0.00284	CcSEcCtD
Vinblastine—Extravasation—Epirubicin—ovarian cancer	4.9e-05	0.00282	CcSEcCtD
Vinblastine—TUBB2B—testis—ovarian cancer	4.83e-05	0.0028	CbGeAlD
Vinblastine—TUBB4B—female reproductive system—ovarian cancer	4.83e-05	0.0028	CbGeAlD
Vinblastine—Convulsion—Melphalan—ovarian cancer	4.82e-05	0.00277	CcSEcCtD
Vinblastine—Discomfort—Topotecan—ovarian cancer	4.78e-05	0.00275	CcSEcCtD
Vinblastine—Rectal haemorrhage—Epirubicin—ovarian cancer	4.73e-05	0.00273	CcSEcCtD
Vinblastine—Cellulitis—Epirubicin—ovarian cancer	4.7e-05	0.00271	CcSEcCtD
Vinblastine—ABCC1—uterine cervix—ovarian cancer	4.59e-05	0.00266	CbGeAlD
Vinblastine—TUBB—testis—ovarian cancer	4.57e-05	0.00265	CbGeAlD
Vinblastine—TUBB4B—bone marrow—ovarian cancer	4.56e-05	0.00264	CbGeAlD
Vinblastine—TUBB2A—testis—ovarian cancer	4.54e-05	0.00263	CbGeAlD
Vinblastine—Thrombocytopenia—Topotecan—ovarian cancer	4.54e-05	0.00261	CcSEcCtD
Vinblastine—Extravasation—Doxorubicin—ovarian cancer	4.53e-05	0.00261	CcSEcCtD
Vinblastine—Decreased appetite—Chlorambucil—ovarian cancer	4.52e-05	0.00261	CcSEcCtD
Vinblastine—Ill-defined disorder—Vinorelbine—ovarian cancer	4.51e-05	0.0026	CcSEcCtD
Vinblastine—Anaemia—Vinorelbine—ovarian cancer	4.49e-05	0.00259	CcSEcCtD
Vinblastine—TUBB6—testis—ovarian cancer	4.48e-05	0.0026	CbGeAlD
Vinblastine—Bone pain—Epirubicin—ovarian cancer	4.46e-05	0.00257	CcSEcCtD
Vinblastine—Pancytopenia—Paclitaxel—ovarian cancer	4.45e-05	0.00257	CcSEcCtD
Vinblastine—Pain—Chlorambucil—ovarian cancer	4.45e-05	0.00256	CcSEcCtD
Vinblastine—Thrombocytopenia—Melphalan—ovarian cancer	4.44e-05	0.00256	CcSEcCtD
Vinblastine—Anorexia—Topotecan—ovarian cancer	4.42e-05	0.00254	CcSEcCtD
Vinblastine—TUBB4B—female gonad—ovarian cancer	4.39e-05	0.00255	CbGeAlD
Vinblastine—Malaise—Vinorelbine—ovarian cancer	4.38e-05	0.00252	CcSEcCtD
Vinblastine—Rectal haemorrhage—Doxorubicin—ovarian cancer	4.38e-05	0.00252	CcSEcCtD
Vinblastine—ABCC1—decidua—ovarian cancer	4.37e-05	0.00253	CbGeAlD
Vinblastine—TUBB4B—vagina—ovarian cancer	4.37e-05	0.00253	CbGeAlD
Vinblastine—Vertigo—Vinorelbine—ovarian cancer	4.36e-05	0.00251	CcSEcCtD
Vinblastine—Leukopenia—Vinorelbine—ovarian cancer	4.35e-05	0.0025	CcSEcCtD
Vinblastine—Cellulitis—Doxorubicin—ovarian cancer	4.35e-05	0.0025	CcSEcCtD
Vinblastine—Anorexia—Melphalan—ovarian cancer	4.32e-05	0.00249	CcSEcCtD
Vinblastine—Feeling abnormal—Chlorambucil—ovarian cancer	4.29e-05	0.00247	CcSEcCtD
Vinblastine—Gastrointestinal pain—Chlorambucil—ovarian cancer	4.26e-05	0.00245	CcSEcCtD
Vinblastine—TUBA1A—lymph node—ovarian cancer	4.24e-05	0.00245	CbGeAlD
Vinblastine—JUN—lymph node—ovarian cancer	4.2e-05	0.00243	CbGeAlD
Vinblastine—Hypertension—Vinorelbine—ovarian cancer	4.19e-05	0.00242	CcSEcCtD
Vinblastine—Depression—Paclitaxel—ovarian cancer	4.17e-05	0.0024	CcSEcCtD
Vinblastine—Paraesthesia—Topotecan—ovarian cancer	4.16e-05	0.0024	CcSEcCtD
Vinblastine—ABCC1—endometrium—ovarian cancer	4.15e-05	0.00241	CbGeAlD
Vinblastine—Bone pain—Doxorubicin—ovarian cancer	4.13e-05	0.00238	CcSEcCtD
Vinblastine—Acute coronary syndrome—Paclitaxel—ovarian cancer	4.12e-05	0.00237	CcSEcCtD
Vinblastine—Abdominal pain—Chlorambucil—ovarian cancer	4.11e-05	0.00237	CcSEcCtD
Vinblastine—Myocardial infarction—Paclitaxel—ovarian cancer	4.1e-05	0.00236	CcSEcCtD
Vinblastine—Neuropathy peripheral—Paclitaxel—ovarian cancer	4.1e-05	0.00236	CcSEcCtD
Vinblastine—Discomfort—Vinorelbine—ovarian cancer	4.08e-05	0.00235	CcSEcCtD
Vinblastine—Paraesthesia—Melphalan—ovarian cancer	4.07e-05	0.00235	CcSEcCtD
Vinblastine—Decreased appetite—Topotecan—ovarian cancer	4.03e-05	0.00232	CcSEcCtD
Vinblastine—Pain—Topotecan—ovarian cancer	3.96e-05	0.00228	CcSEcCtD
Vinblastine—Constipation—Topotecan—ovarian cancer	3.96e-05	0.00228	CcSEcCtD
Vinblastine—Decreased appetite—Melphalan—ovarian cancer	3.94e-05	0.00227	CcSEcCtD
Vinblastine—Vinorelbine—ABCB1—ovarian cancer	3.94e-05	0.0567	CrCbGaD
Vinblastine—ABCC2—female reproductive system—ovarian cancer	3.9e-05	0.00226	CbGeAlD
Vinblastine—TUBB4B—testis—ovarian cancer	3.9e-05	0.00226	CbGeAlD
Vinblastine—Thrombocytopenia—Vinorelbine—ovarian cancer	3.88e-05	0.00224	CcSEcCtD
Vinblastine—Pain—Melphalan—ovarian cancer	3.88e-05	0.00224	CcSEcCtD
Vinblastine—Angina pectoris—Docetaxel—ovarian cancer	3.87e-05	0.00223	CcSEcCtD
Vinblastine—Neoplasm—Epirubicin—ovarian cancer	3.86e-05	0.00223	CcSEcCtD
Vinblastine—Hypersensitivity—Chlorambucil—ovarian cancer	3.83e-05	0.00221	CcSEcCtD
Vinblastine—ABCC1—uterus—ovarian cancer	3.83e-05	0.00222	CbGeAlD
Vinblastine—Feeling abnormal—Topotecan—ovarian cancer	3.82e-05	0.0022	CcSEcCtD
Vinblastine—Gastrointestinal pain—Topotecan—ovarian cancer	3.79e-05	0.00218	CcSEcCtD
Vinblastine—Anorexia—Vinorelbine—ovarian cancer	3.78e-05	0.00218	CcSEcCtD
Vinblastine—Pancytopenia—Docetaxel—ovarian cancer	3.77e-05	0.00217	CcSEcCtD
Vinblastine—Haemoglobin—Paclitaxel—ovarian cancer	3.77e-05	0.00217	CcSEcCtD
Vinblastine—Haemorrhage—Paclitaxel—ovarian cancer	3.75e-05	0.00216	CcSEcCtD
Vinblastine—Asthenia—Chlorambucil—ovarian cancer	3.73e-05	0.00215	CcSEcCtD
Vinblastine—Hypoaesthesia—Paclitaxel—ovarian cancer	3.73e-05	0.00215	CcSEcCtD
Vinblastine—Pharyngitis—Paclitaxel—ovarian cancer	3.72e-05	0.00215	CcSEcCtD
Vinblastine—Abdominal pain—Topotecan—ovarian cancer	3.66e-05	0.00211	CcSEcCtD
Vinblastine—TUBB4A—lymph node—ovarian cancer	3.62e-05	0.0021	CbGeAlD
Vinblastine—Phlebitis—Epirubicin—ovarian cancer	3.6e-05	0.00207	CcSEcCtD
Vinblastine—Neoplasm—Doxorubicin—ovarian cancer	3.57e-05	0.00206	CcSEcCtD
Vinblastine—Diarrhoea—Chlorambucil—ovarian cancer	3.56e-05	0.00205	CcSEcCtD
Vinblastine—Paraesthesia—Vinorelbine—ovarian cancer	3.56e-05	0.00205	CcSEcCtD
Vinblastine—TUBB2B—lymph node—ovarian cancer	3.5e-05	0.00203	CbGeAlD
Vinblastine—Acute coronary syndrome—Docetaxel—ovarian cancer	3.49e-05	0.00201	CcSEcCtD
Vinblastine—Neuropathy peripheral—Docetaxel—ovarian cancer	3.47e-05	0.002	CcSEcCtD
Vinblastine—Myocardial infarction—Docetaxel—ovarian cancer	3.47e-05	0.002	CcSEcCtD
Vinblastine—Decreased appetite—Vinorelbine—ovarian cancer	3.45e-05	0.00199	CcSEcCtD
Vinblastine—Hypersensitivity—Topotecan—ovarian cancer	3.41e-05	0.00197	CcSEcCtD
Vinblastine—Constipation—Vinorelbine—ovarian cancer	3.39e-05	0.00195	CcSEcCtD
Vinblastine—Pain—Vinorelbine—ovarian cancer	3.39e-05	0.00195	CcSEcCtD
Vinblastine—Hypersensitivity—Melphalan—ovarian cancer	3.34e-05	0.00193	CcSEcCtD
Vinblastine—Phlebitis—Doxorubicin—ovarian cancer	3.33e-05	0.00192	CcSEcCtD
Vinblastine—Asthenia—Topotecan—ovarian cancer	3.32e-05	0.00192	CcSEcCtD
Vinblastine—Alopecia—Paclitaxel—ovarian cancer	3.32e-05	0.00191	CcSEcCtD
Vinblastine—TUBB—lymph node—ovarian cancer	3.31e-05	0.00192	CbGeAlD
Vinblastine—Vomiting—Chlorambucil—ovarian cancer	3.31e-05	0.00191	CcSEcCtD
Vinblastine—Agranulocytosis—Docetaxel—ovarian cancer	3.31e-05	0.00191	CcSEcCtD
Vinblastine—TUBB2A—lymph node—ovarian cancer	3.29e-05	0.00191	CbGeAlD
Vinblastine—Feeling abnormal—Vinorelbine—ovarian cancer	3.27e-05	0.00188	CcSEcCtD
Vinblastine—Asthenia—Melphalan—ovarian cancer	3.25e-05	0.00188	CcSEcCtD
Vinblastine—TUBB6—lymph node—ovarian cancer	3.25e-05	0.00188	CbGeAlD
Vinblastine—Gastrointestinal pain—Vinorelbine—ovarian cancer	3.24e-05	0.00187	CcSEcCtD
Vinblastine—Haemoglobin—Docetaxel—ovarian cancer	3.2e-05	0.00184	CcSEcCtD
Vinblastine—Haemorrhage—Docetaxel—ovarian cancer	3.18e-05	0.00183	CcSEcCtD
Vinblastine—Diarrhoea—Topotecan—ovarian cancer	3.17e-05	0.00183	CcSEcCtD
Vinblastine—Hypoaesthesia—Docetaxel—ovarian cancer	3.16e-05	0.00182	CcSEcCtD
Vinblastine—Cerebrovascular accident—Epirubicin—ovarian cancer	3.16e-05	0.00182	CcSEcCtD
Vinblastine—Pharyngitis—Docetaxel—ovarian cancer	3.16e-05	0.00182	CcSEcCtD
Vinblastine—ABCC2—testis—ovarian cancer	3.15e-05	0.00183	CbGeAlD
Vinblastine—Abdominal pain—Vinorelbine—ovarian cancer	3.13e-05	0.00181	CcSEcCtD
Vinblastine—ABCC1—female gonad—ovarian cancer	3.13e-05	0.00181	CbGeAlD
Vinblastine—ABCC1—vagina—ovarian cancer	3.11e-05	0.0018	CbGeAlD
Vinblastine—Diarrhoea—Melphalan—ovarian cancer	3.1e-05	0.00179	CcSEcCtD
Vinblastine—Nausea—Chlorambucil—ovarian cancer	3.09e-05	0.00178	CcSEcCtD
Vinblastine—Dizziness—Topotecan—ovarian cancer	3.06e-05	0.00177	CcSEcCtD
Vinblastine—Ill-defined disorder—Paclitaxel—ovarian cancer	3.03e-05	0.00175	CcSEcCtD
Vinblastine—Anaemia—Paclitaxel—ovarian cancer	3.02e-05	0.00174	CcSEcCtD
Vinblastine—Vincristine—ABCB1—ovarian cancer	2.99e-05	0.043	CrCbGaD
Vinblastine—Vomiting—Topotecan—ovarian cancer	2.95e-05	0.0017	CcSEcCtD
Vinblastine—Malaise—Paclitaxel—ovarian cancer	2.95e-05	0.0017	CcSEcCtD
Vinblastine—Vertigo—Paclitaxel—ovarian cancer	2.93e-05	0.00169	CcSEcCtD
Vinblastine—Cerebrovascular accident—Doxorubicin—ovarian cancer	2.93e-05	0.00169	CcSEcCtD
Vinblastine—Leukopenia—Paclitaxel—ovarian cancer	2.92e-05	0.00168	CcSEcCtD
Vinblastine—Hypersensitivity—Vinorelbine—ovarian cancer	2.92e-05	0.00168	CcSEcCtD
Vinblastine—Headache—Topotecan—ovarian cancer	2.9e-05	0.00167	CcSEcCtD
Vinblastine—Vomiting—Melphalan—ovarian cancer	2.88e-05	0.00166	CcSEcCtD
Vinblastine—Asthenia—Vinorelbine—ovarian cancer	2.84e-05	0.00164	CcSEcCtD
Vinblastine—Convulsion—Paclitaxel—ovarian cancer	2.83e-05	0.00163	CcSEcCtD
Vinblastine—TUBB4B—lymph node—ovarian cancer	2.82e-05	0.00164	CbGeAlD
Vinblastine—Hypertension—Paclitaxel—ovarian cancer	2.82e-05	0.00162	CcSEcCtD
Vinblastine—Alopecia—Docetaxel—ovarian cancer	2.81e-05	0.00162	CcSEcCtD
Vinblastine—ABCC1—testis—ovarian cancer	2.78e-05	0.00161	CbGeAlD
Vinblastine—Nausea—Topotecan—ovarian cancer	2.75e-05	0.00159	CcSEcCtD
Vinblastine—Discomfort—Paclitaxel—ovarian cancer	2.75e-05	0.00158	CcSEcCtD
Vinblastine—Diarrhoea—Vinorelbine—ovarian cancer	2.71e-05	0.00156	CcSEcCtD
Vinblastine—Nausea—Melphalan—ovarian cancer	2.69e-05	0.00155	CcSEcCtD
Vinblastine—Dizziness—Vinorelbine—ovarian cancer	2.62e-05	0.00151	CcSEcCtD
Vinblastine—Angina pectoris—Epirubicin—ovarian cancer	2.61e-05	0.0015	CcSEcCtD
Vinblastine—Thrombocytopenia—Paclitaxel—ovarian cancer	2.61e-05	0.0015	CcSEcCtD
Vinblastine—Anaemia—Docetaxel—ovarian cancer	2.56e-05	0.00147	CcSEcCtD
Vinblastine—Pancytopenia—Epirubicin—ovarian cancer	2.55e-05	0.00147	CcSEcCtD
Vinblastine—Anorexia—Paclitaxel—ovarian cancer	2.54e-05	0.00146	CcSEcCtD
Vinblastine—Vomiting—Vinorelbine—ovarian cancer	2.52e-05	0.00145	CcSEcCtD
Vinblastine—Headache—Vinorelbine—ovarian cancer	2.48e-05	0.00143	CcSEcCtD
Vinblastine—Leukopenia—Docetaxel—ovarian cancer	2.48e-05	0.00143	CcSEcCtD
Vinblastine—Angina pectoris—Doxorubicin—ovarian cancer	2.42e-05	0.00139	CcSEcCtD
Vinblastine—ABCB1—myometrium—ovarian cancer	2.41e-05	0.0014	CbGeAlD
Vinblastine—Convulsion—Docetaxel—ovarian cancer	2.4e-05	0.00138	CcSEcCtD
Vinblastine—Paraesthesia—Paclitaxel—ovarian cancer	2.39e-05	0.00138	CcSEcCtD
Vinblastine—Hypertension—Docetaxel—ovarian cancer	2.39e-05	0.00138	CcSEcCtD
Vinblastine—Pancytopenia—Doxorubicin—ovarian cancer	2.36e-05	0.00136	CcSEcCtD
Vinblastine—Nausea—Vinorelbine—ovarian cancer	2.35e-05	0.00136	CcSEcCtD
Vinblastine—Neuropathy peripheral—Epirubicin—ovarian cancer	2.34e-05	0.00135	CcSEcCtD
Vinblastine—Decreased appetite—Paclitaxel—ovarian cancer	2.32e-05	0.00134	CcSEcCtD
Vinblastine—ABCB1—embryo—ovarian cancer	2.32e-05	0.00134	CbGeAlD
Vinblastine—ABCC2—lymph node—ovarian cancer	2.28e-05	0.00132	CbGeAlD
Vinblastine—Pain—Paclitaxel—ovarian cancer	2.28e-05	0.00131	CcSEcCtD
Vinblastine—Constipation—Paclitaxel—ovarian cancer	2.28e-05	0.00131	CcSEcCtD
Vinblastine—Agranulocytosis—Epirubicin—ovarian cancer	2.23e-05	0.00128	CcSEcCtD
Vinblastine—Thrombocytopenia—Docetaxel—ovarian cancer	2.21e-05	0.00127	CcSEcCtD
Vinblastine—Feeling abnormal—Paclitaxel—ovarian cancer	2.2e-05	0.00127	CcSEcCtD
Vinblastine—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.18e-05	0.00126	CcSEcCtD
Vinblastine—Neuropathy peripheral—Doxorubicin—ovarian cancer	2.17e-05	0.00125	CcSEcCtD
Vinblastine—Haemoglobin—Epirubicin—ovarian cancer	2.16e-05	0.00124	CcSEcCtD
Vinblastine—Anorexia—Docetaxel—ovarian cancer	2.15e-05	0.00124	CcSEcCtD
Vinblastine—Haemorrhage—Epirubicin—ovarian cancer	2.15e-05	0.00124	CcSEcCtD
Vinblastine—Hypoaesthesia—Epirubicin—ovarian cancer	2.13e-05	0.00123	CcSEcCtD
Vinblastine—Pharyngitis—Epirubicin—ovarian cancer	2.13e-05	0.00123	CcSEcCtD
Vinblastine—Abdominal pain—Paclitaxel—ovarian cancer	2.11e-05	0.00121	CcSEcCtD
Vinblastine—Agranulocytosis—Doxorubicin—ovarian cancer	2.06e-05	0.00119	CcSEcCtD
Vinblastine—Paraesthesia—Docetaxel—ovarian cancer	2.03e-05	0.00117	CcSEcCtD
Vinblastine—ABCC1—lymph node—ovarian cancer	2.01e-05	0.00117	CbGeAlD
Vinblastine—Haemoglobin—Doxorubicin—ovarian cancer	1.99e-05	0.00115	CcSEcCtD
Vinblastine—Haemorrhage—Doxorubicin—ovarian cancer	1.98e-05	0.00114	CcSEcCtD
Vinblastine—CYP3A4—female reproductive system—ovarian cancer	1.98e-05	0.00115	CbGeAlD
Vinblastine—Hypoaesthesia—Doxorubicin—ovarian cancer	1.97e-05	0.00114	CcSEcCtD
Vinblastine—Pharyngitis—Doxorubicin—ovarian cancer	1.97e-05	0.00114	CcSEcCtD
Vinblastine—Decreased appetite—Docetaxel—ovarian cancer	1.96e-05	0.00113	CcSEcCtD
Vinblastine—Hypersensitivity—Paclitaxel—ovarian cancer	1.96e-05	0.00113	CcSEcCtD
Vinblastine—CYP2D6—female reproductive system—ovarian cancer	1.95e-05	0.00113	CbGeAlD
Vinblastine—Constipation—Docetaxel—ovarian cancer	1.93e-05	0.00111	CcSEcCtD
Vinblastine—Pain—Docetaxel—ovarian cancer	1.93e-05	0.00111	CcSEcCtD
Vinblastine—Asthenia—Paclitaxel—ovarian cancer	1.91e-05	0.0011	CcSEcCtD
Vinblastine—Alopecia—Epirubicin—ovarian cancer	1.9e-05	0.00109	CcSEcCtD
Vinblastine—ABCB1—epithelium—ovarian cancer	1.89e-05	0.0011	CbGeAlD
Vinblastine—ABCB1—uterine cervix—ovarian cancer	1.87e-05	0.00109	CbGeAlD
Vinblastine—Feeling abnormal—Docetaxel—ovarian cancer	1.86e-05	0.00107	CcSEcCtD
Vinblastine—Gastrointestinal pain—Docetaxel—ovarian cancer	1.85e-05	0.00106	CcSEcCtD
Vinblastine—Diarrhoea—Paclitaxel—ovarian cancer	1.82e-05	0.00105	CcSEcCtD
Vinblastine—Abdominal pain—Docetaxel—ovarian cancer	1.79e-05	0.00103	CcSEcCtD
Vinblastine—ABCB1—decidua—ovarian cancer	1.79e-05	0.00103	CbGeAlD
Vinblastine—CYP2D6—female gonad—ovarian cancer	1.78e-05	0.00103	CbGeAlD
Vinblastine—Dizziness—Paclitaxel—ovarian cancer	1.76e-05	0.00102	CcSEcCtD
Vinblastine—Alopecia—Doxorubicin—ovarian cancer	1.75e-05	0.00101	CcSEcCtD
Vinblastine—Ill-defined disorder—Epirubicin—ovarian cancer	1.73e-05	0.000998	CcSEcCtD
Vinblastine—Anaemia—Epirubicin—ovarian cancer	1.73e-05	0.000995	CcSEcCtD
Vinblastine—ABCB1—endometrium—ovarian cancer	1.69e-05	0.000982	CbGeAlD
Vinblastine—Vomiting—Paclitaxel—ovarian cancer	1.69e-05	0.000977	CcSEcCtD
Vinblastine—Malaise—Epirubicin—ovarian cancer	1.68e-05	0.00097	CcSEcCtD
Vinblastine—Vertigo—Epirubicin—ovarian cancer	1.68e-05	0.000967	CcSEcCtD
Vinblastine—Leukopenia—Epirubicin—ovarian cancer	1.67e-05	0.000963	CcSEcCtD
Vinblastine—Headache—Paclitaxel—ovarian cancer	1.67e-05	0.000962	CcSEcCtD
Vinblastine—Hypersensitivity—Docetaxel—ovarian cancer	1.66e-05	0.000959	CcSEcCtD
Vinblastine—Asthenia—Docetaxel—ovarian cancer	1.62e-05	0.000934	CcSEcCtD
Vinblastine—Convulsion—Epirubicin—ovarian cancer	1.62e-05	0.000932	CcSEcCtD
Vinblastine—Hypertension—Epirubicin—ovarian cancer	1.61e-05	0.000929	CcSEcCtD
Vinblastine—Ill-defined disorder—Doxorubicin—ovarian cancer	1.6e-05	0.000924	CcSEcCtD
Vinblastine—Anaemia—Doxorubicin—ovarian cancer	1.6e-05	0.00092	CcSEcCtD
Vinblastine—Nausea—Paclitaxel—ovarian cancer	1.58e-05	0.000912	CcSEcCtD
Vinblastine—CYP2D6—testis—ovarian cancer	1.58e-05	0.000913	CbGeAlD
Vinblastine—ABCB1—gonad—ovarian cancer	1.57e-05	0.000911	CbGeAlD
Vinblastine—Discomfort—Epirubicin—ovarian cancer	1.57e-05	0.000905	CcSEcCtD
Vinblastine—ABCB1—uterus—ovarian cancer	1.56e-05	0.000905	CbGeAlD
Vinblastine—Malaise—Doxorubicin—ovarian cancer	1.56e-05	0.000898	CcSEcCtD
Vinblastine—Vertigo—Doxorubicin—ovarian cancer	1.55e-05	0.000894	CcSEcCtD
Vinblastine—Leukopenia—Doxorubicin—ovarian cancer	1.55e-05	0.000891	CcSEcCtD
Vinblastine—Diarrhoea—Docetaxel—ovarian cancer	1.55e-05	0.000891	CcSEcCtD
Vinblastine—Convulsion—Doxorubicin—ovarian cancer	1.5e-05	0.000863	CcSEcCtD
Vinblastine—Dizziness—Docetaxel—ovarian cancer	1.49e-05	0.000861	CcSEcCtD
Vinblastine—Thrombocytopenia—Epirubicin—ovarian cancer	1.49e-05	0.00086	CcSEcCtD
Vinblastine—Hypertension—Doxorubicin—ovarian cancer	1.49e-05	0.00086	CcSEcCtD
Vinblastine—Discomfort—Doxorubicin—ovarian cancer	1.45e-05	0.000837	CcSEcCtD
Vinblastine—Anorexia—Epirubicin—ovarian cancer	1.45e-05	0.000837	CcSEcCtD
Vinblastine—Vomiting—Docetaxel—ovarian cancer	1.44e-05	0.000828	CcSEcCtD
Vinblastine—Headache—Docetaxel—ovarian cancer	1.42e-05	0.000816	CcSEcCtD
Vinblastine—ABCB1—female reproductive system—ovarian cancer	1.4e-05	0.000813	CbGeAlD
Vinblastine—Thrombocytopenia—Doxorubicin—ovarian cancer	1.38e-05	0.000796	CcSEcCtD
Vinblastine—Paraesthesia—Epirubicin—ovarian cancer	1.37e-05	0.000789	CcSEcCtD
Vinblastine—Anorexia—Doxorubicin—ovarian cancer	1.34e-05	0.000775	CcSEcCtD
Vinblastine—Nausea—Docetaxel—ovarian cancer	1.34e-05	0.000773	CcSEcCtD
Vinblastine—ABCB1—bone marrow—ovarian cancer	1.33e-05	0.000768	CbGeAlD
Vinblastine—Decreased appetite—Epirubicin—ovarian cancer	1.32e-05	0.000763	CcSEcCtD
Vinblastine—Constipation—Epirubicin—ovarian cancer	1.3e-05	0.000751	CcSEcCtD
Vinblastine—Pain—Epirubicin—ovarian cancer	1.3e-05	0.000751	CcSEcCtD
Vinblastine—ABCB1—female gonad—ovarian cancer	1.28e-05	0.00074	CbGeAlD
Vinblastine—ABCB1—vagina—ovarian cancer	1.27e-05	0.000736	CbGeAlD
Vinblastine—Paraesthesia—Doxorubicin—ovarian cancer	1.27e-05	0.00073	CcSEcCtD
Vinblastine—Feeling abnormal—Epirubicin—ovarian cancer	1.26e-05	0.000724	CcSEcCtD
Vinblastine—Gastrointestinal pain—Epirubicin—ovarian cancer	1.25e-05	0.000718	CcSEcCtD
Vinblastine—Decreased appetite—Doxorubicin—ovarian cancer	1.23e-05	0.000706	CcSEcCtD
Vinblastine—Pain—Doxorubicin—ovarian cancer	1.21e-05	0.000695	CcSEcCtD
Vinblastine—Constipation—Doxorubicin—ovarian cancer	1.21e-05	0.000695	CcSEcCtD
Vinblastine—Abdominal pain—Epirubicin—ovarian cancer	1.2e-05	0.000694	CcSEcCtD
Vinblastine—Feeling abnormal—Doxorubicin—ovarian cancer	1.16e-05	0.00067	CcSEcCtD
Vinblastine—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.15e-05	0.000664	CcSEcCtD
Vinblastine—ABCB1—testis—ovarian cancer	1.13e-05	0.000656	CbGeAlD
Vinblastine—Hypersensitivity—Epirubicin—ovarian cancer	1.12e-05	0.000647	CcSEcCtD
Vinblastine—Abdominal pain—Doxorubicin—ovarian cancer	1.11e-05	0.000642	CcSEcCtD
Vinblastine—Asthenia—Epirubicin—ovarian cancer	1.09e-05	0.00063	CcSEcCtD
Vinblastine—Diarrhoea—Epirubicin—ovarian cancer	1.04e-05	0.000601	CcSEcCtD
Vinblastine—Hypersensitivity—Doxorubicin—ovarian cancer	1.04e-05	0.000599	CcSEcCtD
Vinblastine—Asthenia—Doxorubicin—ovarian cancer	1.01e-05	0.000583	CcSEcCtD
Vinblastine—Dizziness—Epirubicin—ovarian cancer	1.01e-05	0.000581	CcSEcCtD
Vinblastine—Vomiting—Epirubicin—ovarian cancer	9.69e-06	0.000558	CcSEcCtD
Vinblastine—Diarrhoea—Doxorubicin—ovarian cancer	9.65e-06	0.000556	CcSEcCtD
Vinblastine—Headache—Epirubicin—ovarian cancer	9.55e-06	0.00055	CcSEcCtD
Vinblastine—Dizziness—Doxorubicin—ovarian cancer	9.33e-06	0.000537	CcSEcCtD
Vinblastine—Nausea—Epirubicin—ovarian cancer	9.05e-06	0.000522	CcSEcCtD
Vinblastine—Vomiting—Doxorubicin—ovarian cancer	8.97e-06	0.000517	CcSEcCtD
Vinblastine—Headache—Doxorubicin—ovarian cancer	8.83e-06	0.000509	CcSEcCtD
Vinblastine—Nausea—Doxorubicin—ovarian cancer	8.38e-06	0.000483	CcSEcCtD
Vinblastine—ABCB1—lymph node—ovarian cancer	8.21e-06	0.000476	CbGeAlD
Vinblastine—TUBB4A—Metabolism of proteins—CXCL8—ovarian cancer	1.77e-06	8.98e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.76e-06	8.92e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—SLC5A5—ovarian cancer	1.75e-06	8.89e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.74e-06	8.81e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CD—ovarian cancer	1.71e-06	8.68e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PPP2R1A—ovarian cancer	1.69e-06	8.59e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—SLC2A1—ovarian cancer	1.69e-06	8.59e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MAPK3—ovarian cancer	1.67e-06	8.46e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—YAP1—ovarian cancer	1.66e-06	8.43e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.66e-06	8.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.65e-06	8.39e-05	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—ovarian cancer	1.65e-06	8.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—YAP1—ovarian cancer	1.64e-06	8.33e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—CTNNB1—ovarian cancer	1.63e-06	8.28e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MAPK3—ovarian cancer	1.63e-06	8.27e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—XIAP—ovarian cancer	1.63e-06	8.26e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.63e-06	8.24e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP1B1—ovarian cancer	1.62e-06	8.23e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MYC—ovarian cancer	1.62e-06	8.23e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CXCL8—ovarian cancer	1.62e-06	8.21e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FASN—ovarian cancer	1.6e-06	8.11e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PARP1—ovarian cancer	1.59e-06	8.07e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MAPK1—ovarian cancer	1.59e-06	8.05e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SMARCA4—ovarian cancer	1.59e-06	8.05e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MYC—ovarian cancer	1.59e-06	8.05e-05	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—ovarian cancer	1.57e-06	7.98e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MAPK1—ovarian cancer	1.55e-06	7.87e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EREG—ovarian cancer	1.55e-06	7.86e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SLC2A1—ovarian cancer	1.52e-06	7.7e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—ERBB2—ovarian cancer	1.51e-06	7.67e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD8A—ovarian cancer	1.51e-06	7.66e-05	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL6—ovarian cancer	1.51e-06	7.63e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CTNNB1—ovarian cancer	1.49e-06	7.58e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK3—ovarian cancer	1.49e-06	7.57e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MTOR—ovarian cancer	1.49e-06	7.56e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CB—ovarian cancer	1.49e-06	7.56e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PGR—ovarian cancer	1.45e-06	7.37e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MYC—ovarian cancer	1.45e-06	7.36e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPP2R1A—ovarian cancer	1.44e-06	7.3e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.44e-06	7.29e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.43e-06	7.27e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—YAP1—ovarian cancer	1.43e-06	7.25e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.43e-06	7.25e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MAPK1—ovarian cancer	1.42e-06	7.2e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.41e-06	7.16e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CDKN1B—ovarian cancer	1.4e-06	7.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PARP1—ovarian cancer	1.35e-06	6.85e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	1.35e-06	6.83e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—FASN—ovarian cancer	1.34e-06	6.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.34e-06	6.78e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ABCB1—ovarian cancer	1.34e-06	6.78e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYTB—ovarian cancer	1.33e-06	6.76e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.33e-06	6.75e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CTNNB1—ovarian cancer	1.32e-06	6.71e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SLC5A5—ovarian cancer	1.32e-06	6.68e-05	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—AKT1—ovarian cancer	1.31e-06	6.66e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TYMS—ovarian cancer	1.31e-06	6.66e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.31e-06	6.62e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—ovarian cancer	1.3e-06	6.61e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.29e-06	6.55e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PPP2R1A—ovarian cancer	1.29e-06	6.55e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PTEN—ovarian cancer	1.29e-06	6.54e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NME2—ovarian cancer	1.28e-06	6.46e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.27e-06	6.45e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.27e-06	6.44e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.26e-06	6.38e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYTB—ovarian cancer	1.26e-06	6.37e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.25e-06	6.32e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—TLR4—ovarian cancer	1.23e-06	6.24e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.23e-06	6.22e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.22e-06	6.18e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—ovarian cancer	1.19e-06	6.05e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6ST—ovarian cancer	1.18e-06	5.98e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—FASN—ovarian cancer	1.17e-06	5.91e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.17e-06	5.91e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.17e-06	5.91e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NRAS—ovarian cancer	1.15e-06	5.83e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	1.15e-06	5.82e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.11e-06	5.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.11e-06	5.62e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK3—ovarian cancer	1.1e-06	5.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.1e-06	5.57e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.1e-06	5.57e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PPP2R1A—ovarian cancer	1.1e-06	5.55e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.08e-06	5.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.08e-06	5.48e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.08e-06	5.46e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.06e-06	5.39e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CAV1—ovarian cancer	1.06e-06	5.36e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK1—ovarian cancer	1.05e-06	5.31e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EGFR—ovarian cancer	1.05e-06	5.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.05e-06	5.31e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—ovarian cancer	1.04e-06	5.29e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—ovarian cancer	1.03e-06	5.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.02e-06	5.17e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.01e-06	5.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ABCB1—ovarian cancer	1e-06	5.09e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.97e-07	5.06e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CD—ovarian cancer	9.97e-07	5.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.97e-07	5.05e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—ovarian cancer	9.9e-07	5.02e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TYMS—ovarian cancer	9.87e-07	5e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CG—ovarian cancer	9.64e-07	4.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CAV1—ovarian cancer	9.49e-07	4.81e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	9.42e-07	4.78e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.42e-07	4.77e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CA—ovarian cancer	9.1e-07	4.61e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6ST—ovarian cancer	9e-07	4.56e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERBB2—ovarian cancer	8.81e-07	4.46e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ABCB1—ovarian cancer	8.75e-07	4.43e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—ovarian cancer	8.71e-07	4.41e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MTOR—ovarian cancer	8.69e-07	4.41e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CB—ovarian cancer	8.69e-07	4.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.66e-07	4.39e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APC—ovarian cancer	8.65e-07	4.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TYMS—ovarian cancer	8.59e-07	4.36e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CD—ovarian cancer	8.48e-07	4.3e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—ovarian cancer	8.42e-07	4.27e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.37e-07	4.24e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYTB—ovarian cancer	8.22e-07	4.16e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1B—ovarian cancer	8.16e-07	4.13e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—ovarian cancer	8.06e-07	4.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CAV1—ovarian cancer	8.05e-07	4.08e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—ovarian cancer	7.98e-07	4.05e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CAV1—ovarian cancer	7.95e-07	4.03e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—YAP1—ovarian cancer	7.82e-07	3.96e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—ovarian cancer	7.76e-07	3.93e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTNNB1—ovarian cancer	7.71e-07	3.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6ST—ovarian cancer	7.63e-07	3.87e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CD—ovarian cancer	7.6e-07	3.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.6e-07	3.85e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—ovarian cancer	7.51e-07	3.81e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—ovarian cancer	7.43e-07	3.77e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CB—ovarian cancer	7.39e-07	3.74e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—YAP1—ovarian cancer	7.37e-07	3.73e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APC—ovarian cancer	7.33e-07	3.72e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—ovarian cancer	7.33e-07	3.72e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—ovarian cancer	7.24e-07	3.67e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.18e-07	3.64e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.18e-07	3.64e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.07e-07	3.58e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CAV1—ovarian cancer	6.92e-07	3.51e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—ovarian cancer	6.72e-07	3.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERBB2—ovarian cancer	6.72e-07	3.4e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRAS—ovarian cancer	6.7e-07	3.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTOR—ovarian cancer	6.63e-07	3.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CB—ovarian cancer	6.63e-07	3.36e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CD—ovarian cancer	6.45e-07	3.27e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—ovarian cancer	6.42e-07	3.25e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—ovarian cancer	6.38e-07	3.24e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—FASN—ovarian cancer	6.37e-07	3.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CD—ovarian cancer	6.37e-07	3.23e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	6.31e-07	3.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.27e-07	3.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—ovarian cancer	6.22e-07	3.15e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK1—ovarian cancer	6.11e-07	3.1e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—ovarian cancer	6.11e-07	3.09e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.05e-07	3.07e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FASN—ovarian cancer	6.01e-07	3.04e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.91e-07	2.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CTNNB1—ovarian cancer	5.88e-07	2.98e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.8e-07	2.94e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—ovarian cancer	5.77e-07	2.92e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—ovarian cancer	5.73e-07	2.9e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.71e-07	2.89e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB2—ovarian cancer	5.7e-07	2.89e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MTOR—ovarian cancer	5.62e-07	2.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CB—ovarian cancer	5.62e-07	2.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.55e-07	2.81e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	5.54e-07	2.81e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.47e-07	2.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—ovarian cancer	5.4e-07	2.74e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—ovarian cancer	5.3e-07	2.69e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—ovarian cancer	5.27e-07	2.67e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—ovarian cancer	5.17e-07	2.62e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—ovarian cancer	5.16e-07	2.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.15e-07	2.61e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—ovarian cancer	5.12e-07	2.6e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRAS—ovarian cancer	5.11e-07	2.59e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—ovarian cancer	5.03e-07	2.55e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CTNNB1—ovarian cancer	4.98e-07	2.53e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—ovarian cancer	4.9e-07	2.48e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—ovarian cancer	4.89e-07	2.48e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—ovarian cancer	4.88e-07	2.48e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—ovarian cancer	4.86e-07	2.46e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.85e-07	2.46e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	4.83e-07	2.45e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.82e-07	2.44e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—ovarian cancer	4.8e-07	2.43e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—ovarian cancer	4.76e-07	2.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TYMS—ovarian cancer	4.69e-07	2.38e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—ovarian cancer	4.69e-07	2.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK1—ovarian cancer	4.66e-07	2.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—ovarian cancer	4.65e-07	2.36e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.5e-07	2.28e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—ovarian cancer	4.5e-07	2.28e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TYMS—ovarian cancer	4.42e-07	2.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—ovarian cancer	4.4e-07	2.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—ovarian cancer	4.39e-07	2.22e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—ovarian cancer	4.34e-07	2.2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRAS—ovarian cancer	4.33e-07	2.2e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—ovarian cancer	4.33e-07	2.19e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—ovarian cancer	4.18e-07	2.12e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—ovarian cancer	4.15e-07	2.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—ovarian cancer	4.04e-07	2.05e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—ovarian cancer	4.04e-07	2.05e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK1—ovarian cancer	3.95e-07	2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—ovarian cancer	3.95e-07	2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FASN—ovarian cancer	3.93e-07	1.99e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.86e-07	1.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CAV1—ovarian cancer	3.78e-07	1.92e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—ovarian cancer	3.74e-07	1.89e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.73e-07	1.89e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—ovarian cancer	3.73e-07	1.89e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—ovarian cancer	3.68e-07	1.86e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—ovarian cancer	3.58e-07	1.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.58e-07	1.81e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.56e-07	1.81e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.45e-07	1.75e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—ovarian cancer	3.43e-07	1.74e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.38e-07	1.71e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—ovarian cancer	3.31e-07	1.68e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—ovarian cancer	3.3e-07	1.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.25e-07	1.65e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.17e-07	1.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—ovarian cancer	3.17e-07	1.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—ovarian cancer	3.03e-07	1.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.03e-07	1.54e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	2.95e-07	1.49e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.95e-07	1.49e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.89e-07	1.47e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.85e-07	1.45e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—ovarian cancer	2.8e-07	1.42e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—ovarian cancer	2.76e-07	1.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.64e-07	1.34e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.49e-07	1.26e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—ovarian cancer	2.41e-07	1.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.33e-07	1.18e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—ovarian cancer	2.28e-07	1.16e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.15e-07	1.09e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.12e-07	1.08e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.87e-07	9.46e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.63e-07	8.24e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.61e-07	8.16e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.52e-07	7.69e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.41e-07	7.12e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—ovarian cancer	1.31e-07	6.66e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.24e-07	6.28e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.92e-08	5.03e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—ovarian cancer	8.1e-08	4.11e-06	CbGpPWpGaD
